NCT01935960View on ClinicalTrials.gov

Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2016

Conditions
Healthy Subject
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Correlative studies

OTHER

Placebo

Given PO

DRUG

Retinoid 9cUAB30

Given PO

Trial Locations (3)

35233

University of Alabama at Birmingham Cancer Center, Birmingham

52242

University of Iowa/Holden Comprehensive Cancer Center, Iowa City

53792

University of Wisconsin Hospital and Clinics, Madison

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01935960 - Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers | Biotech Hunter | Biotech Hunter